S&P 500   3,956.61 (+1.42%)
DOW   31,825.06 (+1.80%)
QQQ   291.28 (+0.90%)
AAPL   141.91 (+3.14%)
MSFT   259.43 (+2.72%)
FB   193.76 (+0.11%)
GOOGL   2,219.29 (+1.89%)
AMZN   2,105.88 (-2.13%)
TSLA   666.39 (+0.38%)
NVDA   166.37 (-0.34%)
BABA   86.51 (-0.32%)
NIO   15.67 (-4.68%)
AMD   93.55 (+0.05%)
CGC   5.20 (-5.80%)
MU   69.01 (+0.16%)
T   20.81 (+2.01%)
GE   75.64 (+0.52%)
F   12.80 (+2.40%)
DIS   104.73 (+2.26%)
AMC   11.64 (-3.24%)
PFE   53.04 (+1.09%)
PYPL   80.88 (+0.42%)
NFLX   184.24 (-1.13%)
S&P 500   3,956.61 (+1.42%)
DOW   31,825.06 (+1.80%)
QQQ   291.28 (+0.90%)
AAPL   141.91 (+3.14%)
MSFT   259.43 (+2.72%)
FB   193.76 (+0.11%)
GOOGL   2,219.29 (+1.89%)
AMZN   2,105.88 (-2.13%)
TSLA   666.39 (+0.38%)
NVDA   166.37 (-0.34%)
BABA   86.51 (-0.32%)
NIO   15.67 (-4.68%)
AMD   93.55 (+0.05%)
CGC   5.20 (-5.80%)
MU   69.01 (+0.16%)
T   20.81 (+2.01%)
GE   75.64 (+0.52%)
F   12.80 (+2.40%)
DIS   104.73 (+2.26%)
AMC   11.64 (-3.24%)
PFE   53.04 (+1.09%)
PYPL   80.88 (+0.42%)
NFLX   184.24 (-1.13%)
S&P 500   3,956.61 (+1.42%)
DOW   31,825.06 (+1.80%)
QQQ   291.28 (+0.90%)
AAPL   141.91 (+3.14%)
MSFT   259.43 (+2.72%)
FB   193.76 (+0.11%)
GOOGL   2,219.29 (+1.89%)
AMZN   2,105.88 (-2.13%)
TSLA   666.39 (+0.38%)
NVDA   166.37 (-0.34%)
BABA   86.51 (-0.32%)
NIO   15.67 (-4.68%)
AMD   93.55 (+0.05%)
CGC   5.20 (-5.80%)
MU   69.01 (+0.16%)
T   20.81 (+2.01%)
GE   75.64 (+0.52%)
F   12.80 (+2.40%)
DIS   104.73 (+2.26%)
AMC   11.64 (-3.24%)
PFE   53.04 (+1.09%)
PYPL   80.88 (+0.42%)
NFLX   184.24 (-1.13%)
S&P 500   3,956.61 (+1.42%)
DOW   31,825.06 (+1.80%)
QQQ   291.28 (+0.90%)
AAPL   141.91 (+3.14%)
MSFT   259.43 (+2.72%)
FB   193.76 (+0.11%)
GOOGL   2,219.29 (+1.89%)
AMZN   2,105.88 (-2.13%)
TSLA   666.39 (+0.38%)
NVDA   166.37 (-0.34%)
BABA   86.51 (-0.32%)
NIO   15.67 (-4.68%)
AMD   93.55 (+0.05%)
CGC   5.20 (-5.80%)
MU   69.01 (+0.16%)
T   20.81 (+2.01%)
GE   75.64 (+0.52%)
F   12.80 (+2.40%)
DIS   104.73 (+2.26%)
AMC   11.64 (-3.24%)
PFE   53.04 (+1.09%)
PYPL   80.88 (+0.42%)
NFLX   184.24 (-1.13%)
NYSE:MCK

McKesson (MCK) Stock Forecast, Price & News

$327.98
+5.12 (+1.59%)
(As of 05/23/2022 01:16 PM ET)
Add
Compare
Today's Range
$322.86
$328.81
50-Day Range
$290.63
$333.99
52-Week Range
$184.43
$339.94
Volume
13,528 shs
Average Volume
1.20 million shs
Market Capitalization
$47.68 billion
P/E Ratio
45.49
Dividend Yield
0.58%
Beta
0.67
30 days | 90 days | 365 days | Advanced Chart
Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

McKesson logo

About McKesson

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
58155Q10
Employees
75,000
Year Founded
1833

Sales & Book Value

Annual Sales
$263.97 billion
Cash Flow
$32.44 per share
Book Value
($12.33) per share

Profitability

Net Income
$1.11 billion
Pretax Margin
0.73%

Debt

Price-To-Earnings

Miscellaneous

Free Float
144,958,000
Market Cap
$47.68 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/1 Dividend
2/28/2022
Dividend Payable
4/01/2022
Last Earnings
5/05/2022
Today
5/23/2022
Ex-Dividend for 7/1 Dividend
5/31/2022
Dividend Payable
7/01/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
3/31/2023

Social Links


MarketRank

Overall MarketRank

2.69 out of 5 stars

Medical Sector

66th out of 1,416 stocks

Drugs, Proprietaries, & Sundries Industry

4th out of 8 stocks

Analyst Opinion: 1.4Community Rank: 5.0Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -













McKesson (NYSE:MCK) Frequently Asked Questions

Is McKesson a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson
or view top-rated stocks.

Are investors shorting McKesson?

McKesson saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 2,960,000 shares, a drop of 30.0% from the April 15th total of 4,230,000 shares. Based on an average trading volume of 1,270,000 shares, the short-interest ratio is presently 2.3 days. Currently, 2.0% of the company's stock are short sold.
View McKesson's Short Interest
.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for McKesson
.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its earnings results on Thursday, May, 5th. The company reported $5.83 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.06 by $0.23. The firm earned $66.10 billion during the quarter, compared to analysts' expectations of $63.82 billion. McKesson had a net margin of 0.42% and a negative trailing twelve-month return on equity of 538.84%. The company's quarterly revenue was up 11.8% on a year-over-year basis. During the same period last year, the firm posted $5.05 earnings per share.
View McKesson's earnings history
.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Thursday, April 28th. Stockholders of record on Wednesday, June 1st will be given a dividend of $0.47 per share on Friday, July 1st. This represents a $1.88 annualized dividend and a dividend yield of 0.57%. The ex-dividend date is Tuesday, May 31st.
View McKesson's dividend history
.

Is McKesson a good dividend stock?

McKesson pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.58%. McKesson has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of McKesson is 26.07%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 7.40% next year. This indicates that McKesson will be able to sustain or increase its dividend.
View McKesson's dividend history.

How will McKesson's stock buyback program work?

McKesson declared that its Board of Directors has initiated a share buyback program on Tuesday, February 2nd 2021, which permits the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 6.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its shares are undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY 2023 earnings guidance on Monday, May, 23rd. The company provided earnings per share guidance of $22.90-$23.60 for the period, compared to the consensus estimate of $23.10. The company issued revenue guidance of -.

What price target have analysts set for MCK?

12 brokers have issued 12 month price targets for McKesson's shares. Their forecasts range from $230.00 to $380.00. On average, they anticipate McKesson's stock price to reach $326.00 in the next twelve months. This suggests that the stock has a possible downside of 0.6%.
View analysts' price targets for McKesson
or view top-rated stocks among Wall Street analysts.

Who are McKesson's key executives?
McKesson's management team includes the following people:
What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.62%), BlackRock Inc. (7.72%), State Street Corp (4.50%), JPMorgan Chase & Co. (3.98%), Massachusetts Financial Services Co. MA (3.76%) and Pzena Investment Management LLC (1.80%). Company insiders that own McKesson stock include Brian S Tyler, Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Nancy Flores, Sundeep G Reddy, Sundeep G Reddy, Thomas L Rodgers, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends for McKesson
.

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Glenview Capital Management LLC, American Century Companies Inc., Nordea Investment Management AB, Invesco Ltd., Lazard Asset Management LLC, Equity Investment Corp, and State Street Corp. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Nancy Flores, Sundeep G Reddy, Thomas L Rodgers, and Tracy Faber.
View insider buying and selling activity for McKesson
or view top insider-selling stocks.

Which institutional investors are buying McKesson stock?

MCK stock was bought by a variety of institutional investors in the last quarter, including Aaron Wealth Advisors LLC, Acadian Asset Management LLC, 1832 Asset Management L.P., Arrowstreet Capital Limited Partnership, JPMorgan Chase & Co., Ardevora Asset Management LLP, Bank of Nova Scotia, and UBS Group AG.
View insider buying and selling activity for McKesson
or or view top insider-buying stocks.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $327.98.

How much money does McKesson make?

McKesson has a market capitalization of $47.68 billion and generates $263.97 billion in revenue each year. The company earns $1.11 billion in net income (profit) each year or $7.21 on an earnings per share basis.

How many employees does McKesson have?

McKesson employs 75,000 workers across the globe.

Does McKesson have any subsidiaries?

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson Europe Holdings GmbH & Co. KGaA, McKesson Global Procurement & Sourcing Limited, McKesson International Bermuda IP2A Limited, McKesson International Bermuda IP3A Limited, McKesson Medical-Surgical Holdings Inc., McKesson Medical-Surgical Inc., McKesson Medical-Surgical Top Holdings Inc., McKesson Specialty Care Distribution LLC, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Monarch Insurance Company LLC, Moore Medical, NDCHealth, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., US Oncology Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

When was McKesson founded?

McKesson was founded in 1833.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at (972) 446-4800, via email at [email protected], or via fax at 415-983-8453.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.